{"name":"Cadence Pharmaceuticals","permalink":"cadence-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/cadence-pharmaceuticals","homepage_url":"http://www.cadencepharm.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":null,"alias_list":"","email_address":"info@cadencepharm.com","phone_number":"858-436-1400","description":"","created_at":"Tue Dec 15 21:35:04 UTC 2009","updated_at":"Wed Jun 23 03:29:24 UTC 2010","overview":"<p>Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 2010 Cadence resubmitted a New Drug Application for its investigational product candidate, OFIRMEVTM (acetaminophen) injection for the treatment of pain and fever in adults and children. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date for OFIRMEV of November 4, 2010.</p>","image":{"available_sizes":[[[150,43],"assets/images/resized/0009/1445/91445v1-max-150x150.png"],[[250,72],"assets/images/resized/0009/1445/91445v1-max-250x250.png"],[[403,117],"assets/images/resized/0009/1445/91445v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"President & CEO","person":{"first_name":"Theodore","last_name":"R. Schroeder","permalink":"theodore-r-schroeder","image":null}},{"is_past":false,"title":"Director","person":{"first_name":"James","last_name":"Blair","permalink":"james-blair","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$0","funding_rounds":[],"investments":[],"acquisition":null,"acquisitions":[{"price_amount":285000000,"price_currency_code":"USD","term_code":null,"source_url":"http://www.tradingmarkets.com/news/stock-alert/cadx_cadence-pharmaceuticals-to-acquire-incline-therapeutics-998859.html","source_description":"Cadence Pharmaceuticals to acquire Incline Therapeutics","acquired_year":2010,"acquired_month":6,"acquired_day":22,"company":{"name":"Incline Therapeutics","permalink":"incline-therapeutics","image":null}}],"offices":[{"description":"","address1":"12481 High Bluff Drive","address2":"Suite 200","zip_code":"92130","city":"San Diego","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}